Anti-Arthritic Effects of Magnolol in Human Interleukin 1β-Stimulated Fibroblast-Like Synoviocytes and in a Rat Arthritis Model

Fibroblast-like synoviocytes (FLS) play an important role in the pathologic processes of destructive arthritis by producing a number of catabolic cytokines and metalloproteinases (MMPs). The expression of these mediators is controlled at the transcriptional level. The purposes of this study were to evaluate the anti-arthritic effects of magnolol (5,5′-Diallyl-biphenyl-2,2′-diol), the major bioactive component of the bark of Magnolia officinalis, by examining its inhibitory effects on inflammatory mediator secretion and the NF-κB and AP-1 activation pathways and to investigate its therapeutic effects on the development of arthritis in a rat model. The in vitro anti-arthritic activity of magnolol was tested on interleukin (IL)-1β-stimulated FLS by measuring levels of IL-6, cyclooxygenase-2, prostaglandin E2, and matrix metalloproteinases (MMPs) by ELISA and RT-PCR. Further studies on how magnolol inhibits IL-1β-stimulated cytokine expression were performed using Western blots, reporter gene assay, electrophoretic mobility shift assay, and confocal microscope analysis. The in vivo anti-arthritic effects of magnolol were evaluated in a Mycobacterium butyricum-induced arthritis model in rats. Magnolol markedly inhibited IL-1β (10 ng/mL)-induced cytokine expression in a concentration-dependent manner (2.5–25 µg/mL). In clarifying the mechanisms involved, magnolol was found to inhibit the IL-1β-induced activation of the IKK/IκB/NF-κB and MAPKs pathways by suppressing the nuclear translocation and DNA binding activity of both transcription factors. In the animal model, magnolol (100 mg/kg) significantly inhibited paw swelling and reduced serum cytokine levels. Our results demonstrate that magnolol inhibits the development of arthritis, suggesting that it might provide a new therapeutic approach to inflammatory arthritis diseases

Broad Epigenetic Signature of Maternal Care in the Brain of Adult Rats

BACKGROUND: Maternal care is associated with long-term effects on behavior and epigenetic programming of the NR3C1 (GLUCOCORTICOID RECEPTOR) gene in the hippocampus of both rats and humans. In the rat, these effects are reversed by cross-fostering, demonstrating that they are defined by epigenetic rather than genetic processes. However, epigenetic changes at a single gene promoter are unlikely to account for the range of outcomes and the persistent change in expression of hundreds of additional genes in adult rats in response to differences in maternal care. METHODOLOGY/PRINCIPAL FINDINGS: We examine here using high-density oligonucleotide array the state of DNA methylation, histone acetylation and gene expression in a 7 million base pair region of chromosome 18 containing the NR3C1 gene in the hippocampus of adult rats. Natural variations in maternal care are associated with coordinate epigenetic changes spanning over a hundred kilobase pairs. The adult offspring of high compared to low maternal care mothers show epigenetic changes in promoters, exons, and gene ends associated with higher transcriptional activity across many genes within the locus examined. Other genes in this region remain unchanged, indicating a clustered yet specific and patterned response. Interestingly, the chromosomal region containing the protocadherin-α, -β, and -γ (Pcdh) gene families implicated in synaptogenesis show the highest differential response to maternal care. CONCLUSIONS/SIGNIFICANCE: The results suggest for the first time that the epigenetic response to maternal care is coordinated in clusters across broad genomic areas. The data indicate that the epigenetic response to maternal care involves not only single candidate gene promoters but includes transcriptional and intragenic sequences, as well as those residing distantly from transcription start sites. These epigenetic and transcriptional profiles constitute the first tiling microarray data set exploring the relationship between epigenetic modifications and RNA expression in both protein coding and non-coding regions across a chromosomal locus in the mammalian brain

Isotopic shifts with size, culture habitat, and enrichment between the diet and tissues of the Japanese scallop Mizuhopecten yessoensis (Jay, 1857)

Use of stable isotope signatures to trace diet patterns in cultured marine bivalves, particularly when changing culture habitat, requires knowledge of the isotopic shift and enrichment between diet and consumer's tissues. The aim of this study was to determine the patterns of isotope change and the variability of enrichment values (Δδ13C and Δδ15N) in different tissues (muscle, gonad, digestive gland) of the Japanese scallop (Mizuhopecten yessoensis). It was hypothesized that the isotopic signatures of a consumer's tissues changed during settlement, and that the changes were related to variations in the isotopic signatures of food sources and gut contents. Particular attention was paid to the isotope enrichment between the diet and a consumer's tissues using isotope analysis of gut content. Muscle δ15N values decreased significantly 3-5 months post-settlement in a nearshore seabed, concomitant with the ingestion of lower δ15N food. For juvenile scallops, sinking particles (SP) were considered a more important dietary source than suspended particulate organic matter (SPOM), based on the correspondence between SP and gut contents δ13C. Enrichment values (Δδ13C and Δδ15N) varied with tissue and season. Δδ15N was 2.4‰ in muscle, 1.2‰ in gonad, and 0.7‰ in the digestive gland. Δδ13C was 3.2‰ in muscle, 2.3‰ in gonad, and -0.5‰ in the digestive gland. Δδ15N was the lowest in summer (0.3‰), and Δδ13C was the highest in autumn (2.8‰). Δδ15N values were significantly influenced by age, but not Δδ13C. Patterns of isotope ratios and enrichment values may be related to physiological attributes and differences in diet. This is the first study to demonstrate isotopic shift and enrichment encountered in different tissues of a cultured scallop when changing culture habitat

Síndrome de West: a propósito de nove casos

A síndrome de West é forma de epilepsia generalizada que se inicia no primeiro ano de vida, com pico de incidência entre 5 e 8 meses, caracterizada por espasmos ou mioclonias maciças, regressão do desenvolvimento neuropsicomotor e alteração eletrencefalográfica denominada hipsarritmia. Relatamos nove casos de síndrome de West, discutindo aspectos clínicos, etiológicos, evolutivos e terapêuticos